Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Critical view of anaphylaxis epidemiology: open questions and new perspectives

    In contrast to the majority of allergic or hypersensitivity conditions, worldwide anaphylaxis epidemiological data remain sparse with low accuracy, which hampers comparable morbidity statistics. Data can diffe...

    Luciana Kase Tanno, Ana Luiza Bierrenbach in Allergy, Asthma & Clinical Immunology (2018)

  2. Article

    Open Access

    Adherence with epinephrine autoinjector prescriptions in primary care

    The aim of this study was to estimate primary adherence for epinephrine autoinjector (EA) prescriptions in primary care practices in Manitoba, Canada.

    Elissa M. Abrams, Alexander G. Singer, Lisa Lix in Allergy, Asthma & Clinical Immunology (2017)

  3. Article

    Open Access

    Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016

    Mohammad A. Alsayegh, Hanan Alshamali in Allergy, Asthma & Clinical Immunology (2017)

  4. Article

    Open Access

    Fatal anaphylaxis registries data support changes in the who anaphylaxis mortality coding rules

    Anaphylaxis is defined as a severe life-threatening generalized or systemic hypersensitivity reaction. The difficulty of coding anaphylaxis fatalities under the World Health Organization (WHO) International Cl...

    Luciana Kase Tanno, F. Estelle R. Simons in Orphanet Journal of Rare Diseases (2017)

  5. Article

    Open Access

    2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines

    The World Allergy Organization (WAO) Guidelines for the assessment and management of anaphylaxis provide a unique global perspective on this increasingly common, potentially life-threatening disease. Recommend...

    F. Estelle R. Simons, Motohiro Ebisawa in World Allergy Organization Journal (2015)

  6. No Access

    Article

    Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study

    For the first-aid treatment of anaphylaxis, epinephrine (Epi) 0.3 mg intramuscular (IM) injection in the thigh is the drug of choice. Epi auto-injectors are widely recommended for anaphylaxis treatment in comm...

    Mutasem M. Rawas-Qalaji, Shima Werdy, Ousama Rachid in AAPS PharmSciTech (2015)

  7. No Access

    Article

    Hydroxyzine from topical phospholipid liposomal formulations: Evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model

    Hydroxyzine, an effective but sedating H1-antihistamine is given orally to treat allergic skin disorders. This study was performed to assess the peripheral H1-antihistaminic activity and extent of systemic absorp...

    Abeer A W Elzainy, **aochen Gu, F. Estelle R. Simons, Keith J. Simons in AAPS PharmSci (2015)

  8. Article

    Open Access

    Insights and advances in chronic urticaria: a Canadian perspective

    In the past few years there have been significant advances which have changed the face of chronic urticaria. In this review, we aim to update physicians about clinically relevant advances in the classification...

    Gordon Sussman, Jacques Hébert, Wayne Gulliver in Allergy, Asthma & Clinical Immunology (2015)

  9. Article

    Open Access

    International consensus on (ICON) anaphylaxis

    ICON: Anaphylaxis provides a unique perspective on the principal evidence-based anaphylaxis guidelines developed and published independently from 2010 through 2014 by four allergy/immunology organizations. The...

    F Estelle R Simons, Ledit RF Ardusso, M Beatrice Bilò in World Allergy Organization Journal (2014)

  10. Article

    Open Access

    2078- Immunotherapy – 2078. Allergen-specific oral immunotherapy for peanut allergy: a Cochrane systematic review

    Ulugbek Nurmatov, Iris Venderbosch, Graham Devereux in World Allergy Organization Journal (2013)

  11. Article

    Open Access

    Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort

    Patients with severe or difficult-to-treat asthma account for substantial asthma morbidity, mortality, and healthcare burden despite comprising only a small proportion of the total asthma population. TENOR, a ...

    Bradley E. Chipps, Robert S. Zeiger in Current Respiratory Care Reports (2012)

  12. No Access

    Article

    Dissolution Testing of Sublingual Tablets: A Novel In Vitro Method

    In the sublingual (SL) cavity, compared with the gastrointestinal tract, tablets are subjected to minimal physiological agitation, and a limited volume of saliva is available to facilitate disintegration and d...

    Ousama Rachid, Mutasem Rawas-Qalaji, F. Estelle R. Simons in AAPS PharmSciTech (2011)

  13. No Access

    Article

    An Electronic Tongue: Evaluation of the Masking Efficacy of Sweetening and/or Flavoring Agents on the Bitter Taste of Epinephrine

    An epinephrine (E) tablet is under development for sublingual (SL) administration for the first-aid treatment of anaphylaxis; however, the inherent bitterness of E may hinder acceptability by patients, especia...

    Ousama Rachid, F. Estelle R. Simons, Mutasem Rawas-Qalaji in AAPS PharmSciTech (2010)

  14. Article

    Open Access

    Epinephrine: The Drug of Choice for Anaphylaxis--A Statement of the World Allergy Organization

    Anaphylaxis is an acute and potentially lethal multisystem allergic reaction. Most consensus guidelines for the past 30 years have held that epinephrine is the drug of choice and the first drug that should be ...

    Stephen F Kemp, Richard F Lockey, F Estelle R Simons in World Allergy Organization Journal (2008)

  15. No Access

    Article

    Cetirizine from topical phosphatidylcholine-hydrogenated liposomes: Evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model

    Cetirizine, an effective, minimally sedating, second-generation H1-antihistamine is widely used orally to treat allergic skin disorders. This study was performed to assess the peripheral H1-antihistaminic activit...

    Abeer A. W. Elzainy, **aochen Gu, F. Estelle R. Simons, Keith J. Simons in The AAPS Journal (2004)

  16. Article

    Peanut Allergy: Recent Advances

    F Estelle R Simons in Pediatric Research (2003)

  17. Article

    The Benefits of Long-Term Inhaled Glucocorticosteroid Treatment in Children with Asthma Outweigh the Risks

    F Estelle R Simons in Pediatric Research (2001)

  18. No Access

    Article

    Fexofenadine

    F. Estelle R. Simons in Drugs (1998)

  19. No Access

    Article

    Effect of Cimetidine on the Pharmacokinetics and Pharmacodynamics of Chlorpheniramine and Diphenhydramine in Rabbits

    Purpose. The effects of concomitant administration of the H2-receptor antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-receptor antagonists chlorpheniramine and diphenhydramine were s...

    Keith J. Simons, Xueyu Chen, Terry G. Eraser in Pharmaceutical Research (1996)

  20. No Access

    Article

    Effect of the H2-Receptor Antagonist Cimetidine, on the Pharmacokinetics and Pharmacodynamics of the H1-Receptor Antagonists Hydroxyzine and Cetirizine in Rabbits

    The effects of coadministration of the H2-receptor antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1 receptor antagonists hydroxyzine and cetirizine were studied in rabbits. A single do...

    Xueyu Chen, F. Estelle R. Simons, Keith J. Simons in Pharmaceutical Research (1994)

previous disabled Page of 2